FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040997758> ?p ?o ?g. }

• W2040997758 endingPage "301" @default.
• W2040997758 startingPage "296" @default.
• W2040997758 abstract "Patients with nephrotic range proteinuria have a marked increase in the risk of cardiovascular disease. Qualitative and quantitative changes in lipids and lipoproteins contribute to this increased risk with an abundance of atherogenic triglyceride (TG) rich apolipoprotein B containing lipoproteins. TG rich lipoproteins predominate postprandially and are associated with increased risk of coronary heart disease (CHD). Omega-3 fatty acids derived from fish oils have been shown to have beneficial effects on lipids and lipoproteins in patients without proteinuria.17 patients with nephrotic range proteinuria and 17 age and sex matched controls were studied. Postprandial lipaemia was assessed in patients and controls, before and after 8 weeks treatment with 4 g daily of omega-3 fatty acids (Omacor). A standard fat load (90 g) was administered and blood sampling was performed in the fasting state and at 2, 4, 6 and 8h after the fat load. Chylomicrons and VLDL(1) density fraction was isolated from plasma by density ultracentrifugation. Postprandial chylomicron and VLDL(1) triglyceride concentrations were measured and quantified using the incremental area under the curve (AUC) method.Baseline postprandial chylomicron TG AUC was greater in patients compared with controls: median 18.5 mmol/lh (interquartile range 8.9-32.6) vs 9.3 mmol/lh (4.8-14.4) p=0.05. Following treatment patient chylomicron AUC fell [mean reduction 6.8 mmol/lh (95% CI 0.1-13.6) p=0.05]. No significant reduction in chylomicron AUC was observed in the controls [mean reduction 3.9 mmol/lh (95% CI -3.6 to 11.5)]. As a result, following 8 weeks treatment with omega-3 fatty acids, patient and control chylomicron AUC were no longer significantly different [patients 13.5 mmol/lh (7.4-22.9), controls 7.2 mmol/lh (4.6-14.5) both median and IQR, p=nsd]. VLDL(1) TG AUC did not differ at baseline between patients and controls. Furthermore, there was no significant effect on VLDL(1) AUC following treatment in either group.We have shown that there is an excess of postprandial chylomicron density fraction in patients with nephrotic range proteinuria, which is reduced by treatment with omega-3 fatty acids. We suggest that this would be an ideal therapy in combination with statins for this high risk group of patients." @default.
• W2040997758 created "2016-06-24" @default.
• W2040997758 creator A5037853560 @default.
• W2040997758 creator A5041604889 @default.
• W2040997758 creator A5068285451 @default.
• W2040997758 creator A5082071435 @default.
• W2040997758 creator A5085431110 @default.
• W2040997758 date "2009-07-01" @default.
• W2040997758 modified "2023-09-26" @default.
• W2040997758 title "Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria" @default.
• W2040997758 cites W1775749144 @default.
• W2040997758 cites W1874786031 @default.
• W2040997758 cites W1909772243 @default.
• W2040997758 cites W1925532217 @default.
• W2040997758 cites W1962477930 @default.
• W2040997758 cites W1974647064 @default.
• W2040997758 cites W1975936284 @default.
• W2040997758 cites W1990591737 @default.
• W2040997758 cites W1990953214 @default.
• W2040997758 cites W1991386799 @default.
• W2040997758 cites W2001805808 @default.
• W2040997758 cites W2011523983 @default.
• W2040997758 cites W2013717913 @default.
• W2040997758 cites W2021228261 @default.
• W2040997758 cites W2027904194 @default.
• W2040997758 cites W2028676438 @default.
• W2040997758 cites W2029988322 @default.
• W2040997758 cites W2030115183 @default.
• W2040997758 cites W2053731083 @default.
• W2040997758 cites W2076364750 @default.
• W2040997758 cites W2076368854 @default.
• W2040997758 cites W2083461291 @default.
• W2040997758 cites W2088669371 @default.
• W2040997758 cites W2091679838 @default.
• W2040997758 cites W2095885613 @default.
• W2040997758 cites W2101978769 @default.
• W2040997758 cites W2107928904 @default.
• W2040997758 cites W2114356110 @default.
• W2040997758 cites W2125790654 @default.
• W2040997758 cites W2142407152 @default.
• W2040997758 cites W2146220245 @default.
• W2040997758 cites W2154672295 @default.
• W2040997758 cites W2158740401 @default.
• W2040997758 cites W2342049821 @default.
• W2040997758 cites W4232807629 @default.
• W2040997758 doi "https://doi.org/10.1016/j.atherosclerosis.2008.12.002" @default.
• W2040997758 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19150063" @default.
• W2040997758 hasPublicationYear "2009" @default.
• W2040997758 type Work @default.
• W2040997758 sameAs 2040997758 @default.
• W2040997758 citedByCount "4" @default.
• W2040997758 countsByYear W20409977582013 @default.
• W2040997758 countsByYear W20409977582014 @default.
• W2040997758 countsByYear W20409977582016 @default.
• W2040997758 crossrefType "journal-article" @default.
• W2040997758 hasAuthorship W2040997758A5037853560 @default.
• W2040997758 hasAuthorship W2040997758A5041604889 @default.
• W2040997758 hasAuthorship W2040997758A5068285451 @default.
• W2040997758 hasAuthorship W2040997758A5082071435 @default.
• W2040997758 hasAuthorship W2040997758A5085431110 @default.
• W2040997758 hasConcept C11772777 @default.
• W2040997758 hasConcept C126322002 @default.
• W2040997758 hasConcept C134018914 @default.
• W2040997758 hasConcept C185592680 @default.
• W2040997758 hasConcept C2778163477 @default.
• W2040997758 hasConcept C2778199505 @default.
• W2040997758 hasConcept C2778913445 @default.
• W2040997758 hasConcept C2779306644 @default.
• W2040997758 hasConcept C2780072125 @default.
• W2040997758 hasConcept C62746215 @default.
• W2040997758 hasConcept C71924100 @default.
• W2040997758 hasConcept C76318530 @default.
• W2040997758 hasConcept C8243546 @default.
• W2040997758 hasConceptScore W2040997758C11772777 @default.
• W2040997758 hasConceptScore W2040997758C126322002 @default.
• W2040997758 hasConceptScore W2040997758C134018914 @default.
• W2040997758 hasConceptScore W2040997758C185592680 @default.
• W2040997758 hasConceptScore W2040997758C2778163477 @default.
• W2040997758 hasConceptScore W2040997758C2778199505 @default.
• W2040997758 hasConceptScore W2040997758C2778913445 @default.
• W2040997758 hasConceptScore W2040997758C2779306644 @default.
• W2040997758 hasConceptScore W2040997758C2780072125 @default.
• W2040997758 hasConceptScore W2040997758C62746215 @default.
• W2040997758 hasConceptScore W2040997758C71924100 @default.
• W2040997758 hasConceptScore W2040997758C76318530 @default.
• W2040997758 hasConceptScore W2040997758C8243546 @default.
• W2040997758 hasIssue "1" @default.
• W2040997758 hasLocation W20409977581 @default.
• W2040997758 hasLocation W20409977582 @default.
• W2040997758 hasOpenAccess W2040997758 @default.
• W2040997758 hasPrimaryLocation W20409977581 @default.
• W2040997758 hasRelatedWork W1997381223 @default.
• W2040997758 hasRelatedWork W2004682325 @default.
• W2040997758 hasRelatedWork W2022129993 @default.
• W2040997758 hasRelatedWork W2031264915 @default.
• W2040997758 hasRelatedWork W2054797524 @default.
• W2040997758 hasRelatedWork W2107863042 @default.
• W2040997758 hasRelatedWork W2142407152 @default.

• next